Research & Development

For over 20 years, Doppel R&D Department has gained expertise in developing numerous pharmaceutical formulations of Finished Drug Forms (FDF).

From the early formulation stages to the validation and industrialisation process, Doppel R&D Department applies its competence to improve drug efficacy through the development of advanced pharmaceutical formulation.

By providing their skills throughout the entire new-drug approval process, Doppel R&D Department can support clinical and BE studies and manage technical files and specific documentation until the Drug Product application is submitted to Regulatory Autorities.


Doppel Pharma CDMO R&D Department consists of, dynamic, highly specialised scientific staff comprised of 26 people:

Pharmaceutical development
8 FTEs (7 scientists and 1 unit head)

Analytical development
12 FTEs (9 scientists and 3 technicians)

Pre-clinical and clinical staff
3 FTEs (1 scientist, 1 technician, and 1 unit head)

Quality unit
3 FTEs (1 QA manager, 1 GMP compliance manager, and 1 QP)

Doppel R&D: areas of expertise


Established in 1994, Doppel is today recognized as one of Europe’s leading experts in contract R&D and manufacturing. It has start-of-the-art facilities and highest scientific capabilities to service its international pharmaceutical and nutritional clients.